Legal Teams Behind the Deal
MapLight’s IPO was steered by Cooley partners Christian Plaza, Mark Ballantyne, Madison Jones, Katherine Denby, Michael Tuscan, Alessandra Murata, Carly Mitchell, Sonia Nath, Phil Mitchell, and Michael Egan.
Representing the underwriters, Latham & Watkins LLP’s team included Nathan Ajiashvili and Matthew Bush, ensuring smooth sailing through turbulent market conditions.
With this milestone, MapLight Therapeutics shines a light of optimism across a dim IPO landscape — its $251 million debut serving as both a financial victory and a symbol of biotech endurance amid government paralysis.
